Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study

Abstract Background We previously showed that the 10-year cardiovascular disease (CVD) risk threshold to initiate statins for primary prevention depends on the baseline CVD risk, age, sex, and the incidence of statin-related harm outcome and competing risk for non-CVD death. As these factors appear...

Full description

Bibliographic Details
Main Authors: Henock G. Yebyo, Sofia Zappacosta, Hélène E. Aschmann, Sarah R. Haile, Milo A. Puhan
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cardiovascular Disorders
Subjects:
Statins
Primary prevention
Cardiovascular disease
Risk thresholds: benefit-harm analysis
Online Access:http://link.springer.com/article/10.1186/s12872-020-01697-6

Internet

http://link.springer.com/article/10.1186/s12872-020-01697-6

Similar Items